You are here
STUDIES ON A NOVEL HUMAN CARDIOSPECIFIC TRANSCRIPTION FACTOR AND ITS INVOLVEMENT IN OMI/HTRA2 MEDIATED CELL DEATH
- Date Issued:
- 2010
- Abstract/Description:
- Omi/HtrA2 is a mitochondrial serine protease that is known to translocate to the cytoplasm upon induction of apoptosis and to activate caspase-dependent and caspase-independent cell death. The molecular mechanism of Omi/HtrA2ÃÂ's function is not clear but involves degradation of specific substrates. These substrates include cytoplasmic, mitochondrial, as well as nuclear proteins. We have isolated a new Omi/HtrA2 interactor, the THAP5 protein. THAP5 is a fifth member of a large family of transcription factors that are involved in cell proliferation, apoptosis, cell cycle control, chromosome segregation, chromatin modification and transcriptional regulation. THAP5 is an approximately 50kDa nuclear protein, with a restricted pattern of expression. Furthermore, there is no mouse or rat homolog for this protein. THAP5 mRNA is highly expressed in the human heart but some expression is also seen in the brain and skeletal muscle. The normal function of THAP5 in the heart or heart disease is unknown. THAP5 protein level is significantly reduced in the myocardial infarction (MI) area in the heart of patients with coronary artery disease (CAD). This part of the heart sustains most of the cellular damage and apoptosis. Our data clearly show that THAP5 is a specific substrate of the proapoptotic Omi/HtrA2 protease and is cleaved and removed during cell death. The molecular mechanism of THAP5ÃÂ's function is unclear. THAP5 can bind to a specific DNA sequence and repress transcription of a reporter gene. Our work suggests that THAP5 is a tissue specific transcriptional repressor that plays an important role in the normal function of the human heart as well as in the development of heart disease.
Title: | STUDIES ON A NOVEL HUMAN CARDIOSPECIFIC TRANSCRIPTION FACTOR AND ITS INVOLVEMENT IN OMI/HTRA2 MEDIATED CELL DEATH. |
24 views
13 downloads |
---|---|---|
Name(s): |
Puthucode Balakrishnan, Meenakshi, Author Zervos, Antonis, Committee Chair University of Central Florida, Degree Grantor |
|
Type of Resource: | text | |
Date Issued: | 2010 | |
Publisher: | University of Central Florida | |
Language(s): | English | |
Abstract/Description: | Omi/HtrA2 is a mitochondrial serine protease that is known to translocate to the cytoplasm upon induction of apoptosis and to activate caspase-dependent and caspase-independent cell death. The molecular mechanism of Omi/HtrA2ÃÂ's function is not clear but involves degradation of specific substrates. These substrates include cytoplasmic, mitochondrial, as well as nuclear proteins. We have isolated a new Omi/HtrA2 interactor, the THAP5 protein. THAP5 is a fifth member of a large family of transcription factors that are involved in cell proliferation, apoptosis, cell cycle control, chromosome segregation, chromatin modification and transcriptional regulation. THAP5 is an approximately 50kDa nuclear protein, with a restricted pattern of expression. Furthermore, there is no mouse or rat homolog for this protein. THAP5 mRNA is highly expressed in the human heart but some expression is also seen in the brain and skeletal muscle. The normal function of THAP5 in the heart or heart disease is unknown. THAP5 protein level is significantly reduced in the myocardial infarction (MI) area in the heart of patients with coronary artery disease (CAD). This part of the heart sustains most of the cellular damage and apoptosis. Our data clearly show that THAP5 is a specific substrate of the proapoptotic Omi/HtrA2 protease and is cleaved and removed during cell death. The molecular mechanism of THAP5ÃÂ's function is unclear. THAP5 can bind to a specific DNA sequence and repress transcription of a reporter gene. Our work suggests that THAP5 is a tissue specific transcriptional repressor that plays an important role in the normal function of the human heart as well as in the development of heart disease. | |
Identifier: | CFE0003412 (IID), ucf:48409 (fedora) | |
Note(s): |
2010-12-01 Ph.D. Medicine, Burnett College of Biomedical Sciences Masters This record was generated from author submitted information. |
|
Subject(s): |
Cardiospecific protein THAP5 transcription factor apoptosis Omi/HtrA2 |
|
Persistent Link to This Record: | http://purl.flvc.org/ucf/fd/CFE0003412 | |
Restrictions on Access: | public | |
Host Institution: | UCF |